First Patient Enrolled in Merit Medical's PREEMIE Study
Portfolio Pulse from
Merit Medical has enrolled the first patient in its PREEMIE study, which is a multicenter, prospective study aimed at evaluating the safety and efficacy of the Bloom™ Micro Occluder System for treating patent ductus arteriosus in premature infants.
March 10, 2025 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merit Medical has initiated the PREEMIE study to assess the Bloom™ Micro Occluder System's safety and efficacy in treating patent ductus arteriosus in premature infants. This development could enhance the company's product offerings in pediatric care.
The initiation of the PREEMIE study is a significant step for Merit Medical as it explores new applications for its Bloom™ Micro Occluder System. Successful results could lead to increased adoption in pediatric care, potentially boosting sales and enhancing the company's reputation in the medical device industry.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90